Section 3.2: Interpreting Diagnostic Laboratory Panels

AANP Family Nurse Practitioner Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical History & Lifespan Assessment

Section 1.1: Lifespan Health History: Newborn through Geriatric Care Section 1.2: Social Drivers of Health & Cultural Competence Section 1.3: Risk Assessment and Stratification

2 Chapter 2: Physical Examination & Physical Assessment

Section 2.1: Developmental Milestones & Pediatric Exams Section 2.2: Advanced Adult & Geriatric Physical Exams Section 2.3: Identifying Clinical Red Flags & Abuse/Neglect

3 Chapter 3: Diagnostic Screening, Testing, & Interpretation

Section 3.1: Primary Care Screening Guidelines Section 3.2: Interpreting Diagnostic Laboratory Panels Section 3.3: Ordering & Interpreting Imaging Studies Section 3.4: Electrocardiology & Pulmonary Function Tests

4 Chapter 4: Differential Diagnosis of Cardio-Respiratory & Endocrine Disorders

Section 4.1: Differentials in Cardiovascular Conditions Section 4.2: Differentials in Respiratory Conditions Section 4.3: Differentials in Endocrine and Metabolic Disorders

5 Chapter 5: Differential Diagnosis of GI, GU, & Reproductive Disorders

5.1 Differentials in Gastrointestinal Conditions 5.2 Differentials in Genitourinary and Renal Conditions 5.3 Differentials in Reproductive and Women's Health

6 Chapter 6: Differential Diagnosis of Neuro, MSK, Derm, & Psych Disorders

Section 6.1: Differentials in Musculoskeletal and Neurological Disorders Section 6.2: Differentials in Dermatological and Psychiatric Conditions

7 Chapter 7: Pharmacotherapeutic Principles & Prescribing Guidelines

Advanced Pharmacotherapeutic Principles Safe Prescribing in Special Populations Prescription Writing, Regulation, and Controlled Substances

8 Chapter 8: Evidence-Based Management of Common Primary Care Disorders

Section 8.1: Pharmacological Treatment Plans Section 8.2: Non-Pharmacological & Integrative Management Section 8.3: Referrals, Consultations, and Interprofessional Collaboration

9 Chapter 9: Health Promotion, Education, & Care Coordination

Section 9.1: Patient and Caregiver Education Section 9.2: Ethics, Consent, & Legal Scope in Treatment Planning

10 Chapter 10: Clinical Outcome Evaluation & Treatment Modification

Section 10.1: Monitoring Treatment Efficacy & Patient Adherence Section 10.2: Lab & Diagnostic Follow-Up in Care Monitoring Section 10.3: Identifying Adverse Drug Reactions & Complications Section 10.4: Criteria for Care Plan Modification & Escalation

Section 3.2: Interpreting Diagnostic Laboratory Panels

Key Takeaways Explain This Topic AI

Differentiate microcytic anemias (MCV < 80) by checking RDW and ferritin: iron deficiency shows high RDW and low ferritin, while thalassemia trait shows normal RDW and normal/high ferritin.

Macrocytic anemias (MCV > 100) are distinguished by methylmalonic acid (MMA) and clinical features: B12 deficiency shows high MMA and neurological deficits, while folate deficiency shows normal MMA and no neurological symptoms.

Renal and hepatic panels: A BUN/creatinine ratio > 20:1 indicates prerenal azotemia; an AST/ALT ratio >= 2:1 with high GGT indicates alcoholic liver disease.

Thyroid panel: Subclinical hypothyroidism is defined by high TSH and normal free T4; check anti-TPO antibodies before starting levothyroxine in asymptomatic or mildly elevated TSH states.

Lipids: If triglycerides are extremely high (>500 mg/dL), prioritize treatment with fibrates or omega-3 fatty acids first to prevent acute pancreatitis before starting statin therapy for LDL-C.

Last updated: July 2026

Section 3.2: Interpreting Diagnostic Laboratory Panels

Advanced practice nursing requires a systematic approach to laboratory interpretation to formulate accurate differential diagnoses. Board exams frequently test the clinician’s ability to analyze patterns within the Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), thyroid profiles, and lipid panels rather than simply recognizing isolated high or low values.

Complete Blood Count (CBC) and Anemia Differentiation

Evaluating an anemia begins with the hemoglobin (Hgb) and hematocrit (Hct), followed immediately by the Mean Corpuscular Volume (MCV), which categorizes anemias by size: microcytic (<80 fL), normocytic (80–100 fL), or macrocytic (>100 fL).

Microcytic Anemias (MCV < 80 fL)

The primary differentials are Iron Deficiency Anemia (IDA), Thalassemia traits, and Anemia of Chronic Disease (ACD - late stage).

Iron Deficiency Anemia: Characterized by low serum iron, low ferritin (the most sensitive indicator of iron stores, <30 ng/mL), high Total Iron-Binding Capacity (TIBC), and an elevated Red Cell Distribution Width (RDW). The RDW increases early in IDA as the bone marrow releases increasingly smaller red blood cells.

Thalassemia Trait (Alpha or Beta): This is a genetic synthesis defect. It presents with a mild microcytic anemia but with a normal RDW, normal or elevated ferritin, and normal TIBC. The Mentzer index (MCV/RBC ratio) is typically <13 in thalassemia, whereas it is >13 in IDA. The gold standard for confirming beta-thalassemia trait is hemoglobin electrophoresis showing elevated hemoglobin A2 (HbA2) or F (HbF).

Anemia of Chronic Disease (ACD): Typically normocytic but can become microcytic. Ferritin is normal or elevated (as it is an acute-phase reactant), and TIBC is low or normal.

Macrocytic Anemias (MCV > 100 fL)

Macrocytic anemias are subdivided into megaloblastic (impaired DNA synthesis) and non-megaloblastic (caused by liver disease, alcohol use, or hypothyroidism).

Vitamin B12 Deficiency: Often due to pernicious anemia (lack of intrinsic factor) or malabsorption. It is characterized by elevated methylmalonic acid (MMA) and homocysteine levels. Uniquely presents with neurological signs (peripheral neuropathy, ataxia, loss of vibratory sense).

Folate Deficiency: Similar hematological presentation but with normal MMA and elevated homocysteine. Neurological symptoms are absent.

Comprehensive Metabolic Panel (CMP)
Renal Function and Electrolytes

BUN/Creatinine Ratio: A ratio greater than 20:1 indicates prerenal azotemia (dehydration, volume depletion, or GI hemorrhage). In prerenal states, the kidneys reabsorb urea in response to hypovolemia while creatinine excretion is relatively maintained. A ratio between 10:1 and 15:1 indicates intrinsic renal disease (e.g., acute tubular necrosis).

Glomerular Filtration Rate (GFR): The best overall marker of kidney function. A GFR <60 mL/min/1.73m² for 3 months or longer indicates Chronic Kidney Disease (CKD).

Hepatic Function

Aminotransferases (AST and ALT): AST is found in liver, heart, and skeletal muscle; ALT is highly specific to hepatocytes. An AST/ALT ratio of 2:1 or greater, especially with elevated gamma-glutamyl transferase (GGT), is highly suggestive of alcoholic liver disease.

Alkaline Phosphatase (ALP): An enzyme concentrated in the bile ducts and bone. Elevated ALP with normal aminotransferases suggests cholestasis, biliary obstruction, Paget's disease, or bone metastasis. ALP is also physiologically elevated during adolescent growth spurts and pregnancy.

Thyroid Panel Interpretation

Thyroid function testing relies primarily on Third-Generation TSH and Free T4 assays.

Primary Hypothyroidism: TSH is elevated (>4.5 mIU/L) and Free T4 is low (<0.8 ng/dL). Autoimmune thyroiditis (Hashimoto's) is the most common cause; check anti-thyroid peroxidase (anti-TPO) antibodies.

Subclinical Hypothyroidism: TSH is elevated, but Free T4 is within normal limits. Clinicians should monitor patients and consider treatment only if TSH is >10 mIU/L, the patient is pregnant, symptomatic, or has positive anti-TPO antibodies.

Primary Hyperthyroidism: TSH is suppressed (<0.1 mIU/L) and Free T4 (or Free T3) is elevated. Graves' disease is the most common cause.

Subclinical Hyperthyroidism: TSH is suppressed, but Free T4 and Free T3 are normal. This carries risks of atrial fibrillation and osteoporosis in postmenopausal women.

Lipid Panels (AHA/ACC Screening)

Standard lipid panels measure Total Cholesterol, HDL-C, Triglycerides, and calculate LDL-C.

Triglyceride-Induced Pancreatitis: While LDL-C is the primary target for cardiovascular risk reduction, extremely high triglycerides (>500 mg/dL) pose an immediate risk for acute pancreatitis. In these cases, the FNP must prioritize lowering triglycerides using fibrates (e.g., fenofibrate), niacin, or high-dose omega-3 fatty acids before addressing LDL-C with statins.

Clinical Traps and Worked Scenario
Clinical Traps to Avoid

Treating Subclinical Hypothyroidism Prematurely: Do not start levothyroxine for a mild TSH elevation (e.g., 5.8 mIU/L) with normal Free T4 in an asymptomatic, non-pregnant adult without checking anti-TPO antibodies.

Confusing Thalassemia with Iron Deficiency: Do not prescribe iron supplements to a patient with microcytic anemia without confirming iron depletion (low ferritin). In thalassemia trait, iron stores are normal or high; giving iron can cause iatrogenic hemochromatosis.

Relying on Creatinine in Geriatrics: Do not assume a normal creatinine indicates normal renal function in an elderly patient. Reduced muscle mass in older adults limits creatinine production, masking underlying renal impairment. Calculate GFR instead.

Worked Scenario

A 42-year-old female presents with fatigue and cold intolerance. Her physical exam shows mild dry skin and delayed patellar reflex relaxation.

Lab Results:

Hgb: 10.8 g/dL (low)
MCV: 72 fL (low)
RDW: 18.2% (elevated)
Ferritin: 12 ng/mL (low)
TSH: 6.8 mIU/L (high)
Free T4: 1.1 ng/dL (normal)

Interpretation:

Hematology: The patient has microcytic anemia (Hgb 10.8, MCV 72). The elevated RDW and low ferritin (<15 ng/mL) confirm Iron Deficiency Anemia. Iron supplements are indicated.

Endocrinology: The elevated TSH and normal Free T4 represent subclinical hypothyroidism. Because she is symptomatic (fatigue, cold intolerance, dry skin, delayed reflexes) and has concurrent iron deficiency, checking anti-TPO antibodies is the next step. If positive or if symptoms persist, initiating low-dose levothyroxine is appropriate.